| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.023 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.018 | 0.9 |